[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100628731":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":15,"locations":21,"responsibleParty":139,"collaborators":142,"id":146,"slug":147,"hasResults":148,"nctId":149,"briefTitle":150,"officialTitle":150,"acronym":151,"eligibilityCriteria":152,"healthyVolunteers":148,"sex":153,"minAge":154,"maxAge":7,"enrollmentInfo":155,"targetDuration":158,"studyType":159,"phases":7,"briefSummary":160,"conditions":161,"keywords":7,"overallStatus":163,"whyStopped":7,"lastUpdateSubmitDate":164,"lastUpdatePostDateStruct":165,"startDateStruct":168,"completionDateStruct":170,"leadSponsor":172,"locationsCount":173},{"fullName":5,"class":6},"Humanitas Hospital, Italy","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":13},"DEVICE","Radiofrequency Ablation (RFA)","Minimally invasive RFA in T1a renal carcinomas",[14],"Next-generation Radiofrequency Generator (Cambridge Interventional)",[16],{"name":17,"role":18,"phone":19,"phoneExt":7,"email":20},"Vittorio Pedicini, MD","CONTACT","+39335539641","vittorio.pedicini@humanitas.it",[22,34,47,59,71,85,97,109,118,127],{"facility":23,"status":7,"city":24,"state":25,"zip":7,"country":26,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":7},"IRCCS Ospedale San Raffaele","Milan","Milano","Italy","IT",{"type":29,"coordinates":30},"Point",[31,32],9.18951,45.46427,{"lat":32,"lon":31},{"facility":35,"status":7,"city":36,"state":7,"zip":7,"country":26,"countryCode":27,"cosmosGeoPoint":37,"geoPoint":41,"contacts":42},"Fondazione Poliambulanza Istituto Ospedaliero","Brescia",{"type":29,"coordinates":38},[39,40],10.21472,45.53558,{"lat":40,"lon":39},[43,45],{"name":44,"role":18,"phone":7,"phoneExt":7,"email":7},"Claudio Salemi, MD",{"name":44,"role":46,"phone":7,"phoneExt":7,"email":7},"PRINCIPAL_INVESTIGATOR",{"facility":48,"status":7,"city":24,"state":7,"zip":7,"country":26,"countryCode":27,"cosmosGeoPoint":49,"geoPoint":53,"contacts":54},"Istituto Europeo di Onclologia ( IEO)",{"type":29,"coordinates":50},[51,52],12.59836,42.78235,{"lat":52,"lon":51},[55,58],{"name":56,"role":18,"phone":57,"phoneExt":7,"email":7},"Franco Orsi, MD","+39 0257489060",{"name":56,"role":46,"phone":7,"phoneExt":7,"email":7},{"facility":60,"status":7,"city":61,"state":7,"zip":7,"country":26,"countryCode":27,"cosmosGeoPoint":62,"geoPoint":66,"contacts":67},"Policlinico Universitario Campus Bio-Medico","Roma",{"type":29,"coordinates":63},[64,65],11.10642,44.99364,{"lat":65,"lon":64},[68,70],{"name":69,"role":18,"phone":7,"phoneExt":7,"email":7},"Francesco Grasso, MD",{"name":69,"role":46,"phone":7,"phoneExt":7,"email":7},{"facility":72,"status":7,"city":73,"state":7,"zip":7,"country":74,"countryCode":75,"cosmosGeoPoint":76,"geoPoint":80,"contacts":81},"Hospital Clínico Universitario","Barcelona","Spain","ES",{"type":29,"coordinates":77},[78,79],2.15899,41.38879,{"lat":79,"lon":78},[82,84],{"name":83,"role":18,"phone":7,"phoneExt":7,"email":7},"Xavier Serres, MD",{"name":83,"role":46,"phone":7,"phoneExt":7,"email":7},{"facility":86,"status":7,"city":87,"state":7,"zip":7,"country":74,"countryCode":75,"cosmosGeoPoint":88,"geoPoint":92,"contacts":93},"Hospital Universitario Reina Sofía","Córdoba",{"type":29,"coordinates":89},[90,91],-4.77275,37.89155,{"lat":91,"lon":90},[94,96],{"name":95,"role":18,"phone":7,"phoneExt":7,"email":7},"Juan Jose Espejo Herrero, MD",{"name":95,"role":46,"phone":7,"phoneExt":7,"email":7},{"facility":98,"status":7,"city":99,"state":7,"zip":7,"country":74,"countryCode":75,"cosmosGeoPoint":100,"geoPoint":104,"contacts":105},"Hospital Universitario de Leganés (Severo Ochoa)","Madrid",{"type":29,"coordinates":101},[102,103],-3.70256,40.4165,{"lat":103,"lon":102},[106,108],{"name":107,"role":18,"phone":7,"phoneExt":7,"email":7},"Jose Maria Abadal, MD",{"name":107,"role":46,"phone":7,"phoneExt":7,"email":7},{"facility":110,"status":7,"city":99,"state":7,"zip":7,"country":74,"countryCode":75,"cosmosGeoPoint":111,"geoPoint":113,"contacts":114},"Hospital Universitario Fundación Jiménez Díaz",{"type":29,"coordinates":112},[102,103],{"lat":103,"lon":102},[115,117],{"name":116,"role":18,"phone":7,"phoneExt":7,"email":7},"Eduardo Crespo, MD",{"name":116,"role":46,"phone":7,"phoneExt":7,"email":7},{"facility":119,"status":7,"city":99,"state":7,"zip":7,"country":74,"countryCode":75,"cosmosGeoPoint":120,"geoPoint":122,"contacts":123},"Hospital Universitario Puerta de Hierro",{"type":29,"coordinates":121},[102,103],{"lat":103,"lon":102},[124,126],{"name":125,"role":18,"phone":7,"phoneExt":7,"email":7},"Santiago Mendez Alonso, MD",{"name":125,"role":46,"phone":7,"phoneExt":7,"email":7},{"facility":128,"status":7,"city":129,"state":7,"zip":7,"country":74,"countryCode":75,"cosmosGeoPoint":130,"geoPoint":134,"contacts":135},"Hospital Universitario Donostia","San Sebastián",{"type":29,"coordinates":131},[132,133],-5.9,43.56667,{"lat":133,"lon":132},[136,138],{"name":137,"role":18,"phone":7,"phoneExt":7,"email":7},"Jose Luis Del Cura, MD",{"name":137,"role":46,"phone":7,"phoneExt":7,"email":7},{"type":46,"investigatorFullName":140,"investigatorTitle":141,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Vittorio Pedicini","Principal Investigator",[143],{"name":144,"class":145},"SACMI-Sociedad Aragonesa de Cirugìa Minimamante Invasiva","UNKNOWN","100628731","radiofrequency-ablation-multicenter-observational-study-in-renal-oncology-patients-100628731",false,"NCT07465458","Radiofrequency Ablation Multicenter Observational Study in Renal Oncology Patients","RASROP-003","Patient selection criteria will be those typically established by each participating center t with T1a primary renal tumors for which a Multidisciplinary Tumor Board has indicated as candidates for treatment with radiofrequency ablation.I\n\nInclusion Criteria:\n\n* Age ≥18 years\n* Signed informed consent approved by the Ethics Committee prior to the ablation procedure.\n* RCC in stage T1a (size \\\u003C4 cm), single or multiple, histologically demonstrated by percutaneous biopsy before or within 30 days prior to ablation\n* Absence of comorbidities that contraindicate treatment\n* Eastern Cooperative Oncology Group Performance Status (ECOG PS) 0-2 at baseline screening.\n\nExclusion Criteria:\n\n* No specific exclusion criteria are established for this clinical registry due to its observational nature. Each center will apply its own criteria according to its routine clinical practice.","ALL","18 Years",{"count":156,"type":157},226,"ESTIMATED","12 Months","OBSERVATIONAL","This observational study is designed to expand the current database available in the literature and the existing knowledge on the outcomes and safety of radiofrequency ablation (RFA) for the treatment of primary renal cell carcinomas in stage T1a. All interventions and subsequent follow-ups are clinical decisions are independent of the study, given its observational nature.",[162],"Renal Carcinoma","NOT_YET_RECRUITING","2026-03-12",{"date":166,"type":167},"2026-03-16","ACTUAL",{"date":169,"type":157},"2026-03",{"date":171,"type":157},"2028-06",{"name":5,"class":6},10]